Dr. Varas focuses on the economic analysis of antitrust and other competition issues. He has conducted economic studies in the healthcare, life science, telecommunication, and retail industries.
Washington, DC
Pablo Varas focuses on the economic analysis of antitrust and other competition issues. He has conducted economic studies in the healthcare, life sciences, telecommunication, and retail industries. His topics of interest include antitrust, damages, and fair market value.
Dr. Varas is fluent in English and Spanish.
2025 Annual Review of Antitrust Law Developments
Managing Director Michael Koenig, Director Jéssica Dutra, and Director Pablos Varas contributed to the “2025 Annual Review of Antitrust Law Developments” from the ABA Antitrust Law Section.
Economic Lessons from the Novant Health CHS Drama
The abandoned transaction between Novant and Community Hospital System (CHS) for two North Carolina (NC) hospitals received substantial attention from the media, lawyers, and economists. Even though an initial district court ruling rejected FTC’s preliminary injunction request, a subsequent court decision pushed the parties to abandon the deal. This case was not a plain-vanilla deal. Some features made the antitrust discussion and the first instance ruling of particular interest, particularly for economic analysis of hospital mergers and considering deal-specific factors.
Expert Economic Testimony Plays Crucial Role in Puerto Rico Healthcare Antitrust Case
Director Jason Albert provided pivotal testimony in Roberto Vázquez-Ramos, et al. v. Triple-S Salud, et al., which examined allegations of unfair competition and monopolistic practices involving exclusive provider arrangements under Puerto Rico’s government health plan.